I co-founded Zymeworks back in 2003. Over and above the science, technology, finance, IP, growth, success and failures - my journey at Zymeworks made me a better a person with a better appreciation for people for innovation for corporate culture for caring, for diversity and for inclusiveness. I led the company from inception to clinical validation, through an IPO on the NYSE, to peak $1.9B valuation. I led the growth of the company from 2 to nearly 500 people across Vancouver Canada and Seattle. Zymeworks (NYSE: ZYME) is a phase 3 clinical stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers including Gastric and Breast Cancer. Zymeworks combines proprietary molecular simulation technology with high performance computing to design and optimize protein therapeutics. Zymeworks' platform technologies has been validated through 9 licensing deals with Pharma including deals with Merck, J&J, GSK, BMS/Celgene, Lilly. Personally I love innovation; I love risk takers; I love those who are not afraid to go for it I consider myself a big picture thinker, strategist and tactician. And most importantly a husband, and a goofy dad that loves his family more than life itself. I co-founded Zymeworks back in 2003. Over and above the science, technology, finance, IP, growth, success and failures - my journey at Zymeworks made me a better a person with a better appreciation for people for innovation for corporate culture for caring, for diversity and for inclusiveness. I led the company from inception to clinical validation, through an IPO on the NYSE, to peak $1.9B valuation. I led the growth of the company from 2 to nearly 500 people across Vancouver Canada and Seattle. Zymeworks (NYSE: ZYME) is a phase 3 clinical stage biotechnology company developing multi-functional protein therapeutics and drug conjugates for the treatment of various forms of HER2+ cancers including Gastric and Breast Cancer. Zymeworks combines proprietary molecular simulation technology with high performance computing to design and optimize protein therapeutics. Zymeworks' platform technologies has been validated through 9 licensing deals with Pharma including deals with Merck, J&J, GSK, BMS/Celgene, Lilly. Personally I love innovation; I love risk takers; I love those who are not afraid to go for it I consider myself a big picture thinker, strategist and tactician. And most importantly a husband, and a goofy dad that loves his family more than life itself.

• 

  Partner in Amplitude Ventures

  We stand proudly on a foundation of deep experience and a demonstrable body of success creating, building, and growing break-out companies.|